Correlation Between Merck and Mesoblast

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Mesoblast, you can compare the effects of market volatilities on Merck and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Mesoblast.

Diversification Opportunities for Merck and Mesoblast

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Merck and Mesoblast is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Merck i.e., Merck and Mesoblast go up and down completely randomly.

Pair Corralation between Merck and Mesoblast

Considering the 90-day investment horizon Merck Company is expected to generate 0.37 times more return on investment than Mesoblast. However, Merck Company is 2.72 times less risky than Mesoblast. It trades about 0.0 of its potential returns per unit of risk. Mesoblast is currently generating about -0.07 per unit of risk. If you would invest  9,917  in Merck Company on November 2, 2024 and sell it today you would lose (22.00) from holding Merck Company or give up 0.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy89.47%
ValuesDaily Returns

Merck Company  vs.  Mesoblast

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Merck is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Mesoblast 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Mesoblast are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mesoblast displayed solid returns over the last few months and may actually be approaching a breakup point.

Merck and Mesoblast Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Mesoblast

The main advantage of trading using opposite Merck and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.
The idea behind Merck Company and Mesoblast pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm